Prabhudas Lilladher has come out with its fourth quarter (January-March’ 22) earnings estimates for the Healthcare sector. The brokerage house expects Eris Lifesciences to report net profit at Rs 89.2 crore up 30.7% year-on-year (down 11.5% quarter-on-quarter).
Net Sales are expected to increase by 12.2 percent Y-o-Y (down 6.1 percent Q-o-Q) to Rs 312.1 crore, according to Prabhudas Lilladher.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 14.1 percent Y-o-Y (down 11.4 percent Q-o-Q) to Rs 107.9 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More
